The expression levels of ANXA9 and ANXA10 were significantly negatively correlated with the degree of infiltration of the above immune cells, suggesting that patients with BC with high expression of ANXA-B may be more suitable for immunotherapy. The gene discussed is ANXA10; the disease is breast cancer.